Skip to Content
As this is a competitive application process it is strongly recommended
the referring clinician thoroughly complete the application.
The IIHG Exome Analysis for Rare Diseases (EARD) Program is intended for healthcare providers in the State of Iowa who see patients with interesting phenotypes of unknown etiology. The IIHG will provide genetic expertise and complete whole exome sequencing with data analysis and interpretation at no cost to the clinician or family. The clinician must provide phenotypic expertise and attend a multidisciplinary team meeting after the data analysis has been done. The goals of the program are the following:
The IIHG accepts applications on a rolling basis. This is a competitive application process. Please read all of the instructions before completing the application. Applications are reviewed and prioritized by the following criteria:
**The Grand Rounds presentation will focus on the disease presentation, diagnosis, treatment and management with novel insights provided by the family if applicable, the human genetics will be secondary to the story. The presentation will demonstrate how the resources of the IIHG are available to all clinicians and that genomic medicine is a powerful tool to complement all of medicine.